Global Muscle Relaxants Market – Industry Trends and Forecast to 2030

Muscle Relaxant Market Analysis and Size

Muscle relaxants are usually used as anesthetics during surgery and long-term to allow controlled mechanical ventilation in patients in intensive care units. In several patients, sedation is reported as the common adverse effect. Thus, physicians usually advise against driving or operating heavy machinery after muscle relaxant administration. A sudden outbreak of the COVID-19 pandemic imposed stringent lockdown regulations globally, causing interruptions in import and export activities of the global muscle relaxant market.

Data Bridge Market Research analyses a growth rate in the global muscle relaxant market in the forecast period 2023-2030. The expected CAGR of the global muscle relaxant market is tend to be around 7.50% in the mentioned forecast period. The market was valued at USD 1.68 billion in 2022, and it would grow up to USD 3 billion by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Muscle Relaxant Market Scope and Segmentation

Market Definition

Muscle relaxants are commonly used during surgery to prevent muscle movement. They are structurally similar to acetylcholine and cause muscle relaxation by minimizing muscle tension. Some muscle relaxant works on the brain or spinal cord to decrease or block excessively stimulated nerve pathways. These types of muscle relaxants are known as a centrally-acting muscle relaxants.   

Global Muscle Relaxant Market Dynamics

Drivers

• Rising Prevalence of Musculoskeletal Issues

The increasing prevalence of musculoskeletal problems and rising customer awareness of their treatment and management boost the market's growth. Structurally distinct medications are the recent technologically improved muscle relaxants that are used to soothe muscle spasms, discomfort, and hyperreflexia. This boosts the growth of the market.

•  Growing Elderly Population

Life expectancy is growing around the world, which has led to an increase in the aging population. This trend positively impacts the industry by increasing the incidence of the disease and creating per capita demand for its remedies. Thus, this population demands high use of muscle relaxants and boosts market growth.

Opportunities

• Growing Prevalence of Lower Back Pain

According to the records of the World Health Organization (WHO), the non-specific burden of lower back pain has increased significantly globally, which is estimated at 60–70% in industrialized countries, whereas the one-year occurrence rate increased rate 15–45%, adult prevalence 5% per annum and mostly incidence of lower back pain has seen in above 35 age bracket people. Thus, this factor demands more drugs and, as a result, is increasing the market's growth.

• Major Developments by the Market Players

There are numerous developments done by major market players that are boosting the growth of the market. For instance, in September 2019, Ipsen Biopharmaceuticals received U.S. FDA approval for expanded use of Dysport (abobotulinumtoxinA) as an injection to treat children two years of age and older having upper limb spasticity excluding spasticity caused by cerebral palsy. Thus, this leads to market expansion.

Restraints/Challenges

• Adverse Side-Effects of Muscle Relaxants

There are severe side effects related to muscle relaxants, such as dizziness, dry mouth, tiredness, and depression which restrict the market growth.

• High Investment and Strict Regulatory Norms

The growth of the muscle relaxant market is limited by factors such as strict regulatory requirements and the risks associated with muscle relaxants. Being a complex process, the use, separation, and development of raw materials for developing pharmaceutical and biopharmaceutical drugs demand professional and qualified personnel. Thus, all these factors restrict the growth of the demand for muscle relaxant drugs.

This global muscle relaxant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global muscle relaxant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Muscle Relaxant Market

Musculoskeletal pain is witnessed to be the commonest problem in routine medical practice. Most pain sources are associated with muscles or fascia becoming damaged, which then triggers pain. Though COVID-19 primarily affects the lungs and internal organs, musculoskeletal injury from this disease was visible due to marked elevation in creatine kinase and lactate dehydrogenase levels. Moreover, pain management during the COVID-19 pandemic demands attention due to difficulties in accessing hospitals for medical services such as physical therapy and rehabilitation. Thus, COVID-19 left a major impact on global muscle relaxant market.

Recent Developments

• In June 2022, Amneal Pharmaceuticals launched LYVISPAH, which is a baclofen oral granules specialty product approved by the U.S. FDA for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.
• In January 2022 Amneal Pharmaceuticals acquired Saol's Baclofen franchise, including Lioresal and LYVISPAH and a pipeline product under development. The acquisition expands the company's commercial, institutional and specialty portfolio in neurology while adding commercial infrastructure in advance of its entry into the biosimilar institutional market.

Global Muscle Relaxant Market Scope

The global muscle relaxant market is segmented on the basis of type, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Skeletal Muscle Relaxant
• Neuromuscular Relaxant
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Others

Muscle Relaxant Drugs Market Regional Analysis/Insights

The global muscle relaxant market is analysed and market size insights and trends are provided by type, route of administration, end-user, distribution channel as referenced above.

The major countries covered in the global muscle relaxant market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is considered to have the highest lucrative growth in the forecast period due to the rise cases of surgical procedures performed annually and increase prevalence of due to the increased R&D activities on muscle relaxant and well-established health care infrastructure in the region. 

Asia-Pacific is dominating the market due to increased advancement in the technology and growth and expansion of health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Muscle Relaxant Market Share Analysis

The global muscle relaxant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global muscle relaxant market.

Key players operating in the global muscle relaxant market include:

• F. Hoffmann-La Roche Ltd. (Switzerland)

• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Merck & Co., Inc. (U.S.)
• Lilly (U.S.)
• Amgen Inc. (U.S.)
• Actelion Pharmaceuticals Ltd (Switzerland
• Endo International Inc (Ireland)
• Sandoz International GmbH (Switzerland)

Research Methodology: Global Muscle Relaxant Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

SKU-55651